Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 45 - Medicinal preparations containing active ingredients not provided for in groups
Patents for A61K 45 - Medicinal preparations containing active ingredients not provided for in groups (115,020)
07/2000
07/26/2000EP1021404A1 Azetidinone derivatives for the treatment of hcmv infections
07/26/2000EP1021201A1 Use of growth differenciation factor-9 (gdf-9) as a contraceptive
07/26/2000EP1021200A1 Methods and compositions for treating rheumatoid arthritis
07/26/2000EP1021195A1 Treating occlusive peripheral vascular disease and coronary disease with combinations of heparin and an adenoside a2 agonist, or with adenosine
07/26/2000EP1021191A2 Tightening and/or reducing the size of body parts containing fat cells
07/26/2000EP1021177A1 Compositions and methods for prevention and treatment of vascular degenerative diseases
07/26/2000EP1021174A2 Medicaments
07/26/2000EP1021173A1 Use of csaid?tm compounds for the management of uterine contractions
07/26/2000EP1021171A1 Delayed total release gastrointestinal drug delivery system
07/26/2000EP1021169A1 Active agent transport systems
07/26/2000EP1021148A1 Composition and method for acceleration of wound and burn healing
07/26/2000EP0643583B1 Intraoperative, intravascular and endoscopic tumor and lesion detection and therapy
07/26/2000CN1261285A CD 154 blockade therapy for therapeutic protein inhibitor syndrome
07/26/2000CN1261284A Use of a CD40 : CD154 binding interruptor to prevent counter adaptive immune responses, particularly graft rejection
07/25/2000US6093743 Therapeutic methods employing disulfide derivatives of dithiocarbamates and compositions useful therefor
07/25/2000US6093741 Agents with leukotriene B4-like activity as antiherpes viral agents
07/25/2000US6093740 Therapeutic treatment for skin disorders
07/25/2000US6093719 Method and pharmaceutical composition for regulating lipid concentration
07/25/2000US6093711 Enteric-coated chromium picolinate compositions and uses thereof
07/25/2000US6093709 Administering a therapeutic beta isozyme of protein kinase c inhibitor for inducing smooth muscle relaxation and vasodilation
07/25/2000US6093707 17β-nitro-11β-arylsteroids and their derivatives having agonist or antagonist hormonal properties
07/25/2000US6093704 Use of dopamine receptor antagonists in palliative tumor therapy
07/25/2000US6093703 Pharmaceutical compositions, containing S-adenosyl-L-methionine salt, 5-methyl-tetrahydrofolic acid and 5-formyltetrahydrofolic acid
07/25/2000US6093702 Synergistic mixture of 2',3'-dideoxyinosine and hydroxycarbamide; administering to host in given dosage to inhibit human immunodeficiency virus(hiv) in cells
07/25/2000US6093561 Human lysophospholipase
07/25/2000US6093417 Comprising a penetration enhancers to diffuse the therapeutic agents through the tympanic membrane into the middle and inner ear; drug delivery
07/25/2000US6093411 Compositions for regulating skin appearance
07/25/2000US6093398 Treatment of a natural or artificial tissue comprising extracellular matrix components to inhibit contraction
07/25/2000US6093395 Co-administration of interleukin-3 mutant polypeptides with CSF's for multi-lineage hematopoietic cell production
07/25/2000US6093391 Peptide compositions containing polyoxyethylene-polyoxypropylene block copolymers that are useful in treatment of diseases and disorders with reduced side effects, ease in administering to desired target site,
07/25/2000CA2167688C Methods and compositions for inhibiting uridine secretion
07/25/2000CA1341060C Use of amylin agonists in the treatment of diabetes mellitus
07/22/2000CA2258312A1 Matrix containing nephrite jade powder as a main component
07/20/2000WO2000042220A1 Nucleic acids, kits, and methods for the diagnosis, prognosis and treatment of glaucoma and related disorders
07/20/2000WO2000042216A2 Genetic predisposition to abnormal calcification conditions
07/20/2000WO2000042211A1 Methods of screening protease inhibitors, of inducing mice susceptible to hiv protease inhibitor-induced dyslipidemia, and genes associated therewith
07/20/2000WO2000042201A2 Human peptidases
07/20/2000WO2000042172A2 Human homologues of proteins regulated by circadian rhythms
07/20/2000WO2000042073A1 Antagonists of tweak and of tweak receptor and their use to treat immunological disorders
07/20/2000WO2000042070A1 Mammalian alpha-helical protein - 12
07/20/2000WO2000042060A1 Bis-amino acid sulfonamides containing n-terminally a substituted benzyl group as hiv protease inhibitors
07/20/2000WO2000042050A1 Sulfated phosphatidylinositols, their preparation and use
07/20/2000WO2000042042A2 High affinity inhibitors for target validation and uses thereof
07/20/2000WO2000042029A1 1-heterocycle substituted diarylamines
07/20/2000WO2000042026A1 Non-peptide glp-1 agonists
07/20/2000WO2000042002A1 Sulphohydroxamic acids and sulphohydroxamates and their use as mek inhibitors
07/20/2000WO2000041994A1 4-arylamino, 4-aryloxy, and 4-arylthio diarylamines and derivatives thereof as selective mek inhibitors
07/20/2000WO2000041730A1 A composition and method for the enhancement of the efficacy of drugs
07/20/2000WO2000041724A1 Modulation of systemic memory t cell trafficking
07/20/2000WO2000041719A1 Methods of using a neurotrophin and its analogues for the treatment of gastrointestinal hypomotility disorders
07/20/2000WO2000041715A1 New dialysis method
07/20/2000WO2000041712A1 Inhibiting development of microvessels within vascular walls
07/20/2000WO2000041700A1 Use of estrogens and delta-gonadien-21-ol-3,20-diones in the treatment or prophylaxis of cerebral degenerative disorders
07/20/2000WO2000041699A1 Use of estrogens and delta-gonadien-21-ol-3,20-diones
07/20/2000WO2000041696A1 Use of 5-ht5-ligands in the treatment of neurodegenerative and neuropsychiatric disturbances
07/20/2000WO2000041692A2 Compositions having improved stability
07/20/2000WO2000041686A1 Treatment of hypertension with compounds that inhibit the destruction of enkephalins or endorphins
07/20/2000WO2000041684A1 A pharmaceutical combination for the treatment of depression
07/20/2000WO2000041681A2 MEDICINAL FORMULATIONS CONTAINING AN OPIOID AND AN α-ANTAGONIST
07/20/2000WO2000041680A1 Pharmaceutical mixture comprising a combination of a profen and other active compounds
07/20/2000WO2000041678A1 Methods for treating ovarian cancer, poly(phosphoester) compositions, and biodegradable articles for same
07/20/2000WO2000041565A1 Method for increasing productivity in breeder hens
07/20/2000WO2000041548A2 Methods for glucagon suppression
07/20/2000WO2000041545A2 Regulators of the pct or smoothened pathway, compositions and uses related thereto
07/20/2000WO2000041540A2 Herbal supplement for increased muscle strength and endurance for athletes
07/20/2000WO2000041526A2 Use of s-triazines for treating apicomplexan parasitic infections
07/20/2000WO2000041516A2 Reagents and methods useful for detecting diseases of the breast
07/20/2000WO2000041514A2 Conjugates of colony stimulating factors for targeting and imaging infection and inflammation
07/20/2000WO2000041505A2 Anthranilic acid derivatives
07/20/2000WO2000041504A2 Use of tertbutylhydroquinone for lowering blood cholesterol and/or blood triblycerides
07/20/2000WO2000041497A2 Use of apoptosis inducing agents in the treatment of (auto)immune diseases
07/20/2000WO2000041473A2 Use of 3-isoxazolidinones and hydroxylamine acids for the treatment of infections
07/20/2000WO2000041472A2 Binding partners for 5-ht5-receptors for the treatment of migraine
07/20/2000WO2000041463A2 Combination of hepatitis b vaccine with antiviral agents
07/20/2000WO2000028999A3 Methods of treating tardive dyskinesia and other movement disorders
07/20/2000WO2000024885A3 p53 MORPHOLINO-BASED ANTISENSE
07/20/2000WO2000020590A3 G-protein coupled receptor proteins
07/20/2000WO2000020041A3 Removal of preexisting antibodies to enhance the effectiveness of a therapeutic viral immunogenic agent
07/20/2000WO2000019990A3 Rar antagonists as male anti-fertility agents
07/20/2000WO2000018370A3 Liquid pharmaceutical for oral delivery
07/20/2000WO2000017358A3 Human chaperone proteins
07/20/2000WO2000015246A3 Regulation of lung tissue by hedgehog-like polypeptides, and formulations and uses related thereto
07/20/2000WO2000015176A3 Treatment of carcinomas using squalamine in combination with other anti-cancer agents or modalities
07/20/2000WO2000012140A8 Method for labeling biopolymers using isotopes
07/20/2000WO2000010598B1 Recombinant botulinium toxin for the treatment of mucus hypersecretion
07/20/2000WO2000002857A9 Bis-indole derivatives and their use as antiinflammatory agents
07/20/2000WO1997025042A8 Use of an agonist of ppar-alpha and ppar-gamma for the treatment of syndrom x
07/20/2000DE19901687A1 Opioide Analgetika mit kontrollierter Wirkstofffreisetzung Opioid analgesics controlled release
07/20/2000DE19901683A1 Analgetikum mit kontrollierter Wirkstofffreisetzung Analgesic with controlled release of active ingredient
07/20/2000DE19855704A1 Mittel zur Behandlung der Symptome der Parkinsonschen Krankheit Agents for treating the symptoms of Parkinson's disease
07/20/2000DE19855013A1 Androgen- und Progesteron-Rezeptor bindendes Hormon Response Element Androgen and progesterone receptor binding hormone response element
07/20/2000CA2370042A1 Regulators of the pct or smoothened pathway, compositions and uses related thereto
07/20/2000CA2363847A1 Treatment of hypertension with compounds that inhibit the destruction of enkephalins or endorphins
07/20/2000CA2360588A1 Human homologues of proteins regulated by circadian rhythms
07/20/2000CA2360584A1 Mammalian alpha-helical protein - 12
07/20/2000CA2360464A1 Human peptidases
07/20/2000CA2360366A1 Use of 3-isoxazolidinones and hydroxylamine acids for the treatment of infections
07/20/2000CA2360358A1 Compositions having improved stability
07/20/2000CA2360227A1 Pharmaceutical mixture comprising a combination of a profen and other active compounds
07/20/2000CA2359798A1 Methods of screening protease inhibitors, of inducing mice susceptible to hiv protease inhibitor-induced dyslipidemia, and genes associated therewith
1 ... 964 965 966 967 968 969 970 971 972 973 974 975 976 977 978 979 980 981 982 983 984 ... 1151